Prostate Cancer

Researcher receives $9 million grant to launch gene therapy trials

Published in Medical Letter on the CDC and FDA, March 7th, 2004

Henry Ford Hospital researcher has been awarded a $9 million grant by the U.S. National Institutes of Health to study the effectiveness of gene therapy as a treatment for prostate cancer.

The treatment, developed over the last few years by Svend Freytag, PhD, division head of radiation oncology at Henry Ford, is a new approach that uses gene therapy to enhance the effectiveness of radiation therapy.

"I believe this research will eventually yield high cure rates for prostate cancer and possibly other forms of cancer as well," said Freytag.

Later in 2004, a clinical trial will begin involving 130 patients. In one group, 65 patients...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2004-03-07)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry